Invizix, formerly Geminii Health, a company developing sleep-time bioelectronic therapies for age-related metabolism-driven diseases, today announced that it has been selected as a finalist for the ...

Scientists have developed an experimental diabetes and obesity pill that works in a completely different way from drugs like ...

A newly published review article highlights the emerging importance of the immunoproteasome in the development and progression of diabetes and its wide-ranging complications, offering fresh ...

A research team has unveiled an adrenal independent pathway, the hypothalamus-sympathetic-liver (HSL) axis, to mediate stress-induced glucose release. Their study is published in Nature Communications ...

Meal timing may be an underused tool ...